Donald Jensen to Cytochrome P-450 CYP3A Inhibitors
This is a "connection" page, showing publications Donald Jensen has written about Cytochrome P-450 CYP3A Inhibitors.
Connection Strength
0.030
-
Randomized study of danoprevir/ritonavir-based therapy for HCV genotype 1 patients with prior partial or null responses to peginterferon/ribavirin. J Hepatol. 2015 Feb; 62(2):294-302.
Score: 0.030